Source link : https://www.newshealth.biz/health-news/europe-approves-neutropenia-and-schizophrenia-treatments/
The European Medicines Agency (EMA) has approved Ryzneuta (efbemalenograstim alfa) as a treatment to reduce the duration of neutropenia and the incidence of febrile neutropenia in adults treated with cytotoxic chemotherapy for cancer. Ryzneuta is a granulocyte colony-stimulating factor that acts on hematopoietic cells by binding to specific cell surface receptors and increases the production […]
Author : News Health
Publish date : 2024-01-26 21:00:55
Copyright for syndicated content belongs to the linked Source.